Form 4 Filing for Gabrielle Sulzberger - Eli Lilly & Co.

Gabrielle Sulzberger, a director at Eli Lilly & Co., acquired 5.013 shares of common stock on March 16, 2026, at a price of $989.12 per share. This acquisition was made in lieu of cash compensation and will be settled in shares following her separation from service, as per the Lilly Directors' Deferral Plan. Following this transaction, Ms. Sulzberger now owns 2976.209 shares of common stock directly. The filing was signed by Jonathan Groff on behalf of Ms. Sulzberger on March 17, 2026.